Post-progression survival after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor for advanced non-small cell lung cancer patients harboring epidermal growth factor receptor mutations.

被引：0
|
作者：
Kogure, Yoshihito
Kitagawa, Chiyoe
Oki, Masahide
Saka, Hideo
机构：
[1] Nagoya Med Ctr, Nagoya, Aichi, Japan
[2] Natl Hosp Org Nagoya Med Ctr, Nagoya, Aichi, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e19005
引用
收藏
页数：1
相关论文
共 50 条
  • [1] POST-PROGRESSION SURVIVAL AFTER TREATMENT WITH EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR FOR ADVANCED NON-SMALL CELL LUNG CANCER PATIENTS HARBORING EPIDERMAL GROWTH FACTOR RECEPTOR MUTATIONS
    Kogure, Yoshihito
    Ise, Yuko
    Murakami, Yasushi
    Hori, Kazumi
    Nakahata, Masashi
    Oka, Saori
    Ryuge, Misaki
    Tokojima, Masatoshi
    Kitagawa, Chiyoe
    Oki, Masahide
    Saka, Hideo
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1158 - S1158
  • [2] Activity of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Patients with Non-small Cell Lung Cancer Harboring Rare Epidermal Growth Factor Receptor Mutations
    De Pas, Tommaso
    Toffalorio, Francesca
    Manzotti, Michela
    Fumagalli, Caterina
    Spitaleri, Gianluca
    Catania, Chiara
    Delmonte, Angelo
    Giovannini, Monica
    Spaggiari, Lorenzo
    de Braud, Filippo
    Barberis, Massimo
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (11) : 1895 - 1901
  • [3] Early radiographic response to epidermal growth factor receptor-tyrosine kinase inhibitor in non-small cell lung cancer patients with epidermal growth factor receptor mutations: A prospective study
    Chang, John W. C.
    Hou, Ming-Mo
    Hsieh, Jia-Juan
    Cheung, Yun-Chung
    Wang, Hung-Ming
    Chen, Jen-Shi
    Wang, Cheng-Hsu
    Chen, Chih-Hung
    Yeh, Kun-Yun
    Ou, Li-Ying
    Hsieh, Chia-Hsun
    Wu, Hong-Dar Isaac
    Chen, Ying-Tsong
    Chang, Il-Chi
    Huang, Shiu-Feng
    BIOMEDICAL JOURNAL, 2015, 38 (03) : 221 - 228
  • [4] The Efficacy and Safety of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Combined With Thymosin in Advanced Non-Small Cell Lung Cancer Patients Harboring Active Epidermal Growth Factor Receptor Mutations
    Feng, Yongdong
    Zhu, Guangkuo
    Lang, Song
    Hao, Ping
    Li, Guanghui
    Chen, Fanglin
    Zhuo, Wenlei
    Duan, Yuzhong
    Zhang, Anmei
    Chen, Zhengtang
    Sun, Jianguo
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [5] Effectiveness Of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors On Non-Small Cell Lung Cancer Harboring Rare EGFR Mutations
    Chang, L. -C.
    Chen, K. -Y.
    Shih, J. -Y.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [6] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer With Uncommon Mutations
    Kanazu, Masaki
    Naoki, Yoko
    Shiroyama, Takayuki
    Tamiya, Motohiro
    Tamiya, Akihiro
    Omachi, Naoki
    Okishio, Kyoichi
    Suzuki, Hidekazu
    Okamoto, Norio
    Morishita, Naoko
    Hirashima, Tomonori
    Atagi, Shinji
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
  • [7] Rebiopsy of Non-Small Cell Lung Cancer Patients With Acquired Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Hata, Akito
    Katakami, Nobuyuki
    Yoshioka, Hiroshige
    Takeshita, Jumpei
    Tanaka, Kosuke
    Nanjo, Shigeki
    Fujita, Shiro
    Kaji, Reiko
    Imai, Yukihiro
    Monden, Kazuya
    Matsumoto, Takeshi
    Nagata, Kazuma
    Otsuka, Kyoko
    Tachikawa, Ryo
    Tomii, Keisuke
    Kunimasa, Kei
    Iwasaku, Masahiro
    Nishiyama, Akihiro
    Ishida, Tadashi
    Nishimura, Yoshihiro
    CANCER, 2013, 119 (24) : 4325 - 4332
  • [8] Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy
    Sari, Murat
    Aydiner, Adnan
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (01) : 132 - 138
  • [9] IMPACT OF EPIDERMAL GROWTH FACTOR RECEPTOR-TYROSINE KINASE INHIBITOR TREATMENT IN ADVANCED NON-SMALL CELL LUNG CANCER: A META-ANALYSIS
    Lee, C. K.
    Brown, C.
    Gralla, R.
    Hirsh, V.
    Inoue, A.
    Gebski, V.
    Yang, C. J.
    ANNALS OF ONCOLOGY, 2012, 23 : 414 - 414
  • [10] Ganetespib in Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-resistant Non-small Cell Lung Cancer
    Kurihara, Eisuke
    Shien, Kazuhiko
    Torigoe, Hidejiro
    Takeda, Tatsuaki
    Takahashi, Yuta
    Ogoshi, Yusuke
    Yoshioka, Takahiro
    Namba, Kei
    Sato, Hiroki
    Suzawa, Ken
    Yamamoto, Hiromasa
    Soh, Junichi
    Okazaki, Mikio
    Shien, Tadahiko
    Tomida, Shuta
    Toyooka, Shinichi
    ANTICANCER RESEARCH, 2019, 39 (04) : 1767 - 1775
12345